159 related articles for article (PubMed ID: 11104831)
1. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
Assié MB; Koek W
Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
[TBL] [Abstract][Full Text] [Related]
2. Differential effects of WAY-100135 on the decrease in 5-hydroxytryptamine release induced by buspirone and NAN-190.
Routledge C; Gurling J; Ashworth-Preece MA; Dourish CT
Eur J Pharmacol; 1995 Apr; 276(3):281-4. PubMed ID: 7601215
[TBL] [Abstract][Full Text] [Related]
3. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
Meller E; Goldstein M; Bohmaker K
Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
[TBL] [Abstract][Full Text] [Related]
4. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
Hjorth S; Pettersson G
Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
[TBL] [Abstract][Full Text] [Related]
5. Role of the medial prefrontal cortex in 5-HT1A receptor-induced inhibition of 5-HT neuronal activity in the rat.
Hajós M; Hajós-Korcsok E; Sharp T
Br J Pharmacol; 1999 Apr; 126(8):1741-50. PubMed ID: 10372816
[TBL] [Abstract][Full Text] [Related]
6. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced defaecation in rats: role of central 5-HT1A receptors.
Croci T; Landi M; Bianchetti A; Manara L
Br J Pharmacol; 1995 May; 115(1):203-9. PubMed ID: 7647978
[TBL] [Abstract][Full Text] [Related]
8. Effect of acute and repeated administration of 5-HT1A receptor agonists on 5-HT release in rat brain in vivo.
Sharp T; McQuade R; Bramwell S; Hjorth S
Naunyn Schmiedebergs Arch Pharmacol; 1993 Oct; 348(4):339-46. PubMed ID: 7904048
[TBL] [Abstract][Full Text] [Related]
9. S 14671: a naphtylpiperazine 5-hydroxytryptamine1A agonist of exceptional potency and high efficacy possessing antagonist activity at 5-hydroxytryptamine1C/2 receptors.
Millan MJ; Rivet JM; Canton H; Lejeune F; Bervoets K; Brocco M; Gobert A; Lefebvre de Ladonchamps B; Le Marouille-Girardon S; Verriele L
J Pharmacol Exp Ther; 1992 Aug; 262(2):451-63. PubMed ID: 1323650
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of 8-OH-DPAT-induced elevation of plasma corticotrophin by the 5-HT1A receptor antagonist WAY100635.
Critchley DJ; Childs KJ; Middlefell VC; Dourish CT
Eur J Pharmacol; 1994 Oct; 264(1):95-7. PubMed ID: 7828650
[TBL] [Abstract][Full Text] [Related]
11. GH4ZD10 cells expressing rat 5-HT1A receptors coupled to adenylyl cyclase are a model for the postsynaptic receptors in the rat hippocampus.
Fowler CJ; Ahlgren PC; Brännström G
Br J Pharmacol; 1992 Sep; 107(1):141-5. PubMed ID: 1330157
[TBL] [Abstract][Full Text] [Related]
12. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
13. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
[TBL] [Abstract][Full Text] [Related]
14. Neuronal circuits involved in the anxiolytic effects of the 5-HT1A receptor agonists 8-OH-DPAT ipsapirone and buspirone in the rat.
Schreiber R; De Vry J
Eur J Pharmacol; 1993 Nov; 249(3):341-51. PubMed ID: 7904566
[TBL] [Abstract][Full Text] [Related]
15. Increase of noradrenaline release in the hypothalamus of freely moving rat by postsynaptic 5-hydroxytryptamine1A receptor activation.
Suzuki M; Matsuda T; Asano S; Somboonthum P; Takuma K; Baba A
Br J Pharmacol; 1995 Jun; 115(4):703-11. PubMed ID: 7582494
[TBL] [Abstract][Full Text] [Related]
16. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
17. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.
Sharp T; Backus LI; Hjorth S; Bramwell SR; Grahame-Smith DG
Eur J Pharmacol; 1990 Feb; 176(3):331-40. PubMed ID: 1970304
[TBL] [Abstract][Full Text] [Related]
18. Discriminative stimulus properties of the 5-HT1A receptor biased agonists NLX-101 and F13714, in rats trained to discriminate 8-OH-DPAT from saline.
Broadbear JH; Depoortere RY; Vacy K; Ralph D; Tunstall BJ; Newman-Tancredi A
Behav Pharmacol; 2021 Dec; 32(8):652-659. PubMed ID: 34751175
[TBL] [Abstract][Full Text] [Related]
19. The potent activity of the 5-HT1A receptor agonists, S 14506 and S 14671, in the rat forced swim test is blocked by novel 5-HT1A receptor antagonists.
Schreiber R; Brocco M; Gobert A; Veiga S; Millan MJ
Eur J Pharmacol; 1994 Dec; 271(2-3):537-41. PubMed ID: 7705455
[TBL] [Abstract][Full Text] [Related]
20. Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat.
Assié MB; Lomenech H; Ravailhe V; Faucillon V; Newman-Tancredi A
Br J Pharmacol; 2006 Sep; 149(2):170-8. PubMed ID: 16921393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
